Financials
Financial year 2025
Van lent Pharma from Bornem, company number BE0774450473, closed financial year 2025 with a result of € 80,052 after tax. For that financial year Van lent Pharma recorded a gross margin of € 107,430 and equity of € 82,552. Compared with financial year 2024, the result moved from € 4,745 to € 80,052. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 15, 2026.
€ 82,552
▼ 11% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 80,052
▲ € 75,308 vs 2024
Profit after tax over the fiscal year.
€ 74,192
▼ 22% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 90,764 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
€ 6,730
Loans from banks and other lenders, long and short.
€ 151
▼ 86% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 5,777
▲ 39% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 54,891 | € 55,254 | € 8,446 | € 107,430 | ▲ € 98,984 |
| Profit after taxes | € 39,818 | € 46,202 | € 4,745 | € 80,052 | ▲ € 75,308 |
| Equity | € 42,318 | € 88,519 | € 93,264 | € 82,552 | ▼ 11% |
| Total debts | € 21,349 | € 23,870 | € 9,418 | € 13,733 | ▲ 46% |
| Cash | € 44,319 | € 90,515 | € 95,333 | € 74,192 | ▼ 22% |
| Retained profit | € 39,818 | € 86,019 | € 90,764 | € 80,052 | ▼ 12% |
| Dividend | € 0 | € 0 | € 0 | € 90,764 | |
| Bank debt | € 0 | € 0 | € 0 | € 6,730 | |
| Balance sheet total | € 63,667 | € 112,390 | € 102,682 | € 96,286 | ▼ 6% |
Key figures of Van lent Pharma, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Van lent Pharma?
What happened at Van lent Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 80,052 (▲ € 75,308 vs 2024). Source: NBB ↗
- New establishment in Bornem. KBO
- Start of the company according to the CBE. KBO
In short
From € 39,818 profit in 2022 to € 80,052 profit in 2025.
Paid € 47,499 in corporate taxes since 2022.
Best year ever: 2025, with € 80,052 profit.
Paid out € 90,764 in dividends to the owners in total.
A new publication or filing at Van lent Pharma? We notify you, reason included.
Follow Van lent PharmaDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Van lent Pharma is Lissa Van lent.
Directors
According to the 2025 annual accounts
Lissa Van lent
Andere functie
Establishments
Establishment units
Physical locations of this company
Karel Van Doorslaerlaan(MAR) 68
2880 Bornem
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0774.450.473
- VAT number
- BE 0774.450.473
- Registered office
- Karel Van Doorslaerlaan(MAR) 68, 2880 Bornem
- Names & denominations
- Van lent Pharma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 22 September 2021
- Peppol
- Active · Active since 22 Oct 2025
- Activities · NACE
Overige zakelijke dienstverlening, neg